Received Mar 23, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (UNKNOWN)) | UNKNOWN MANUFACTURER | UNK | UNK | — |
| FLUX | INFLUENZA (SEASONAL) (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
body aches and a horrific headache ache; body aches and a horrific headache ache; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of general body pain in a female patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Flu unspecified (Influenza vaccine) for prophylaxis and COVID-19 VACCINE for prophylaxis. Concurrent medical conditions included immunocompromised (taking immunosuppressant drugs). On an unknown date, the patient received Shingrix, Influenza vaccine and COVID-19 VACCINE. On an unknown date, an unknown time after receiving Shingrix and Influenza vaccine and an unknown time after receiving COVID-19 VACCINE, the patient experienced general body pain (Verbatim: body aches and a horrific headache ache) and headache (Verbatim: body aches and a horrific headache ache). The outcome of the general body pain and headache were not reported. It was unknown if the reporter considered the general body pain and headache to be related to Shingrix and Influenza vaccine. It was unknown if the company considered the general body pain and headache to be related to Shingrix and Influenza vaccine. Additional Information: GSK receipt date 12-MAR-2026 This case was reported by a consumer via interactive digital media. The patient had body aches and a horrific headache ache after receiving their first dose of SHINGRIX, covid booster and flu shot at the same time. The patient reported stopping their immune suppressant during this time. The batch number was not provided, and we are unable to contact the reporter.
Immunocompromised (taking immunosuppressant drugs)